Jocil Limited
JOCIL · NSE · Basic Materials
StocksWizard rates Jocil Limited a Strong Buy, scoring 77/100 on our blended model. At ₹152.16 it trades below our blended DCF and relative-multiples fair value of ₹280.42, implying roughly 84% upside to that estimate — we read the stock as undervalued by 84%. Financial health scores 54/100 (grade C), in the safe band on the Altman Z-score, with a Piotroski F-score of 3/9. It clears 8 of 12 investability checks, with durability 31, valuation 90 and momentum 95 on our 0–100 scales.
These are StocksWizard's own estimates from end-of-day public data — see how we calculate them. For information only, not investment advice.
With a 20% margin of safety, our buy-below price is ₹224.34.
Piotroski F-score 3/9 — quality of earnings & balance sheet.
Investability checklist
- ✕ROE above 15%4.0%
- –Low debt (D/E < 0.5)
- ✕Positive free cash flow
- ✓Revenue growth > 10%49%
- ✓Earnings growing478%
- ✕Net margin ≥ 10%0.8%
- ✓Current ratio > 1.53.08
- ✓Below our fair value
- ✓Margin of safety ≥ 20%
- ✓Above 200-day average
- ✓Above 50-day average
- –Positive 1-year return
- ✓Altman Z in safe zoneZ 3.16
- ✕Piotroski ≥ 73/9
1-year price
EOD · 2026-06-19Our scores
Durability rewards strong, low-debt, profitable businesses; Valuation rewards stocks cheap vs their sector; Momentum rewards strong price trends.
Key fundamentals
SWOT snapshot
Strengths
- •Financially solid — Altman Z 3.16.
Weaknesses
- •Low return on equity (4.0%).
- •Weak Piotroski score (3/9).
Opportunities
- •Earnings growing (478% YoY).
- •Revenue growing (49% YoY).
- •Trading in our value buy zone versus sector peers.
- •Trades ~84% below our estimated fair value.
About Jocil Limited
Jocil Limited manufactures and sells stearic acids, fatty acids, soap noodles, toilet soaps, glycerine, and industrial oxygen in India. It operates through Chemicals, Soap, and Power segments. The company offers contract manufacturing services; and generates power from biomass power plant and wind energy generators
More in Basic Materials
All stocksOur verdict, fair value, financial-health and checklist are StocksWizard's own estimates, computed from public end-of-day data using standard models (DCF, relative valuation, Altman Z, Piotroski). For information only — not investment advice or a recommendation. Verify independently before investing.